Literature DB >> 17934086

Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases.

Gaëlle Leroux, Nathalie Costedoat-Chalumeau, Jean-Sébastien Hulot, Zahir Amoura, Camille Francès, Guy Aymard, Philippe Lechat, Jean-Charles Piette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17934086      PMCID： PMC2111622          DOI： 10.1136/ard.2007.072587

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.

Authors:  M L Jewell; D P McCauliffe
Journal:  J Am Acad Dermatol       Date:  2000-06       Impact factor: 11.527

2.  Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus.

Authors:  P Rahman; D D Gladman; M B Urowitz
Journal:  J Rheumatol       Date:  1998-09       Impact factor: 4.666

3.  Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus.

Authors:  Nathalie Costedoat-Chalumeau; Zahir Amoura; Jean-Sébastien Hulot; Guy Aymard; Gaëlle Leroux; Donata Marra; Philippe Lechat; Jean-Charles Piette
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

4.  Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.

Authors:  Nathalie Costedoat-Chalumeau; Zahir Amoura; Jean-Sébastien Hulot; Hala Abou Hammoud; Guy Aymard; Patrice Cacoub; Camille Francès; Bertrand Wechsler; Du Le Thi Huong; Pascale Ghillani; Lucile Musset; Philippe Lechat; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2006-10

5.  Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study.

Authors:  N O Ghaussy; W L Sibbitt; C R Qualls
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

6.  Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis.

Authors:  Karen H Costenbader; Daniel J Kim; Jehanna Peerzada; Shahin Lockman; Dolores Nobles-Knight; Michelle Petri; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2004-03
  6 in total
  7 in total

Review 1.  New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.

Authors:  Daniel J Wallace; Vineet S Gudsoorkar; Michael H Weisman; Swamy R Venuturupalli
Journal:  Nat Rev Rheumatol       Date:  2012-07-17       Impact factor: 20.543

Review 2.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

3.  Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma.

Authors:  Jan Dutz; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2011-10       Impact factor: 8.551

4.  Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Authors:  Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

5.  Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus.

Authors:  Dong Xu; Xin You; Zhengang Wang; Qingyu Zeng; Jianhua Xu; Lindi Jiang; Lu Gong; Fengqi Wu; Jieruo Gu; Yi Tao; Jinwei Chen; Jiuliang Zhao; Mengtao Li; Yan Zhao; Xiaofeng Zeng
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

Review 6.  Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

Authors:  Jucélio Pereira Moura Filho; Raiza Luna Peixoto; Lívia Gomes Martins; Sillas Duarte de Melo; Ligiana Leite de Carvalho; Ana Karine F da Trindade C Pereira; Eutilia Andrade Medeiros Freire
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

7.  Disease severity and prophylactic measures in patients with cutaneous lupus erythematosus: results of a worldwide questionnaire-based study.

Authors:  Dominik Samotij; Justyna Szczęch; Victoria P Werth; Fukumi Furukawa; Annegret Kuhn; Jacek C Szepietowski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.